| Product Code: ETC9958780 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Agoraphobia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Agoraphobia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Agoraphobia Market - Industry Life Cycle |
3.4 United States (US) Agoraphobia Market - Porter's Five Forces |
3.5 United States (US) Agoraphobia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Agoraphobia Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Agoraphobia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health issues in the United States |
4.2.2 Growing acceptance and understanding of anxiety disorders like agoraphobia |
4.2.3 Rise in demand for effective treatment options for agoraphobia patients |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders leading to underreporting and undertreatment |
4.3.2 Limited access to mental health services and specialists in certain regions of the United States |
4.3.3 High cost of therapy and medications for agoraphobia treatment |
5 United States (US) Agoraphobia Market Trends |
6 United States (US) Agoraphobia Market, By Types |
6.1 United States (US) Agoraphobia Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Agoraphobia Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Agoraphobia Market Revenues & Volume, By Selective serotonin reuptake inhibitors, 2021- 2031F |
6.1.4 United States (US) Agoraphobia Market Revenues & Volume, By Norepinephrine reuptake inhibitors, 2021- 2031F |
6.2 United States (US) Agoraphobia Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Agoraphobia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 United States (US) Agoraphobia Market Revenues & Volume, By Private clinics, 2021- 2031F |
7 United States (US) Agoraphobia Market Import-Export Trade Statistics |
7.1 United States (US) Agoraphobia Market Export to Major Countries |
7.2 United States (US) Agoraphobia Market Imports from Major Countries |
8 United States (US) Agoraphobia Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted annually |
8.2 Percentage increase in the number of individuals seeking help for anxiety disorders |
8.3 Adoption rate of telemedicine solutions for agoraphobia treatment |
9 United States (US) Agoraphobia Market - Opportunity Assessment |
9.1 United States (US) Agoraphobia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Agoraphobia Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Agoraphobia Market - Competitive Landscape |
10.1 United States (US) Agoraphobia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Agoraphobia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |